MACROGENICS INC (MGNX)
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company’s product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
MacroGenics, Inc.
NASDAQ:MGNXHealthcare · Biotechnology
+0.84%$2.40
AH$2.40+0.00%vs close
Mkt Cap$153M
Float62.12M
O/S63.75M
Vol
$ Vol
RVOL
Inst Own75.9%
SI8.2%
Earnings
Dilution
Financials Summary
Revenue$149.5M
Net Income-$74.62M
Total Assets$256.85M
Free Cash Flow-$82.95M
Debt & Equity
Debt 66%
Equity 34%
Total Debt$106.76M
Total Equity$55.59M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in MGNX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$256.85M
Liabilities$201.25M
Accounts Receivable$13.37M
Accounts Payable$4.79M
Inventory$7.91M
PP&E (Net)$35.52M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $149.5M | $148.34M | $57.19M | $150.02M | $75.64M | $97.76M | $62.02M | $60.12M | $155.52M | $86.58M | $100.85M | $47.26M | $56.75M | $59.65M | $47.05M |
| YoY Growth | 0.8% | 159.4% | -61.9% | 98.3% | -22.6% | 57.6% | 3.2% | -61.3% | 79.6% | -14.2% | 113.4% | -16.7% | -4.8% | 26.8% | - |
| Cost of Revenue | $43.18M | $12.3M | $8.22M | $7.38M | $2.65M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $106.32M | $136.04M | $48.97M | $142.63M | $72.99M | $97.76M | $62.02M | $60.12M | $155.52M | $86.58M | $100.85M | $47.26M | $56.75M | $62.87M | $47.05M |
| Gross Margin | 71.1% | 91.7% | 85.6% | 95.1% | 96.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 105.4% | 100.0% |
| Research and Development | $140M | $177.19M | $166.58M | $207.03M | $214.58M | $193.2M | $195.31M | $190.83M | $147.23M | $122.09M | $98.27M | $70.19M | $45.39M | $44.47M | $39.94M |
| Selling, General, and Administrative | $39.16M | $71.05M | $52.19M | $58.95M | $63.01M | $42.74M | $46.06M | $40.5M | $32.65M | $29.83M | $22.77M | $15.93M | $11.09M | $10.19M | $10.87M |
| Other | $0 | -$1.62M | -$1.56M | -$1.92M | -$1.8M | -$7.12M | -$2.16M | -$247K | -$2.23M | -$5.3M | $42K | -$533K | -$88K | $0 | -$9.01M |
| Total Operating Expenses | $179.16M | $246.62M | $217.22M | $264.05M | $275.79M | $228.82M | $239.21M | $231.33M | $177.66M | $146.62M | $121.04M | $85.58M | $56.39M | $54.66M | $41.8M |
| Operating Income (EBIT) | -$72.84M | -$110.58M | -$168.24M | -$121.42M | -$202.79M | -$131.06M | -$177.19M | -$171.21M | -$22.14M | -$60.04M | -$20.18M | -$38.31M | $366K | $8.21M | $5.25M |
| Operating Margin | -48.7% | -74.5% | -294.2% | -80.9% | -268.1% | -134.1% | -285.7% | -284.8% | -14.2% | -69.3% | -20.0% | -81.1% | 0.6% | 13.8% | 11.2% |
| Interest Expense | $8.51M | $1.11M | $1.43M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $3.4M | $9.42M | $9.69M | $1.7M | $680K | $800K | $3.4M | $0 | $0 | $0 | $0 | $0 | $0 | $6K | $8K |
| Other Income (Expense) | -$2.45M | $44.56M | $159.19M | $1.66M | $680K | $1.32M | $25.37M | -$247K | $2.52M | $1.51M | $42K | $2K | -$627K | $157K | $1.47M |
| Income Before Tax (EBT) | -$75.29M | -$66.02M | -$9.06M | -$119.76M | -$202.12M | -$129.74M | -$151.81M | -$171.45M | -$19.63M | -$58.53M | -$20.14M | -$38.31M | -$261K | $8.36M | $6.72M |
| Income Tax Expense | -$672K | $944K | $0 | $0 | $0 | $0 | $0 | -$247K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$74.62M | -$66.97M | -$9.06M | -$119.76M | -$202.12M | -$129.74M | -$151.81M | -$171.45M | -$19.63M | -$58.53M | -$20.14M | -$38.31M | -$261K | $8.36M | $6.72M |
| Net Income Margin | -49.9% | -45.1% | -15.8% | -79.8% | -267.2% | -132.7% | -244.8% | -285.2% | -12.6% | -67.6% | -20.0% | -81.1% | -0.5% | 14.0% | 14.3% |
| Supplementary Data | |||||||||||||||
| EPS | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 | -3.16 | -4.19 | -0.54 | -1.69 | -0.63 | -1.40 | -0.01 | 0.46 | 0.37 |
| Diluted EPS | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 | -3.16 | -4.19 | -0.54 | -1.69 | -0.63 | -1.40 | -0.01 | 0.46 | 0.37 |
| Weighted Average OS | 63.16M | 62.62M | 61.93M | 61.41M | 59.94M | 52.44M | 48.08M | 40.93M | 36.10M | 34.69M | 31.80M | 27.37M | 25.54M | 18.14M | 18.14M |
| EBITDA | -$59.61M | -$57.37M | $2.02M | -$107.89M | -$190.86M | -$119.1M | -$164.88M | -$162.05M | -$14.91M | -$52.43M | -$17.32M | -$36.49M | $1.56M | $9.17M | $6.4M |
| EBITDA Margin | -39.9% | -38.7% | 3.5% | -71.9% | -252.3% | -121.8% | -265.8% | -269.5% | -9.6% | -60.6% | -17.2% | -77.2% | 2.7% | 15.4% | 13.6% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $57.22M | $182.84M | $100.96M | $108.88M | $123.47M | $181.13M | $126.47M | $220.13M | $211.73M | $84.1M | $196.17M | $157.59M | $116.48M | $47.74M | $55.22M |
| Short-Term Investments | $132.7M | $18.83M | $128.85M | $45.46M | $120.15M | $91.4M | $89.28M | $12.73M | $93.39M | $192.9M | $142.88M | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $189.91M | $201.67M | $229.81M | $154.35M | $243.62M | $272.53M | $215.76M | $232.86M | $305.12M | $277M | $339.05M | $157.59M | $116.48M | $47.74M | $55.22M |
| Accounts Receivable | $13.37M | $4.31M | $10.37M | $56.22M | $10.39M | $23.08M | $12.74M | $29.58M | $13.64M | $2.76M | $1.22M | $2.94M | $2M | $2.05M | $3.4M |
| Inventory | $7.91M | $0 | $1.22M | $1.45M | $4.39M | $0 | $0 | $0 | $0 | -$7.99M | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $8.74M | $11.51M | $9.95M | $10.16M | $0 | $0 | $0 | $0 | $383K | $8.69M | $305K | $0 | $0 | $0 | $0 |
| Total Current Assets | $219.94M | $217.49M | $251.34M | $222.18M | $279.56M | $312.59M | $239.78M | $269.12M | $322.3M | $283.95M | $342.38M | $164.74M | $119.46M | $49.93M | $58.66M |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $35.52M | $42.61M | $45.69M | $56.91M | $54.29M | $61.52M | $68.41M | $56.71M | $49.98M | $17.96M | $14.84M | $6.79M | $5.04M | $3.27M | $3.29M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7.99M | $0 | $825K | $405K | $405K | $582K |
| Deferred Tax Assets | $0 | $0 | $0 | $9.04M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.39M | $10.46M | $1.39M | $1.38M | $1.4M | $4.62M | $4.3M | $6.29M | $1.6M | $1.37M | $2.04M | $1.54M | $885K | $147K | $148K |
| Total Long-Term Assets | $36.91M | $53.06M | $47.08M | $67.33M | $55.69M | $66.15M | $72.72M | $63.01M | $51.59M | $27.32M | $16.89M | $9.15M | $6.33M | $3.82M | $4.02M |
| Other Assets | $0 | -$8.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $256.85M | $261.65M | $298.42M | $289.51M | $335.25M | $378.74M | $312.5M | $332.13M | $373.88M | $311.26M | $359.27M | $173.89M | $125.78M | $53.75M | $62.68M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $4.79M | $5.01M | $6.44M | $4.9M | $15.5M | $8.03M | $4.31M | $4M | $2.45M | $4M | $2.97M | $1.67M | $3.17M | $3.74M | $11.05M |
| Short-Term Debt | $5.18M | $0 | $0 | $4.73M | $0 | $0 | $0 | $0 | $298K | $1.59M | $2.02M | $1.64M | $1.44B | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $10.92M | $16.32M | $21.65M | $9.99M | $0 | $0 | $0 | $21.72M | $7.2M | $4.26M | $5.87M | $14.25M | $20.27M | $24.12M | $31.65M |
| Other Current Liabilities | $22.23M | $0 | $0 | $29M | $20.65M | $4.46M | $10.7M | $1.02M | $1.22M | $1.32M | $1.64M | $1.6M | -$1.44B | $629K | $534K |
| Total Current Liabilities | $43.12M | $55.53M | $56.11M | $48.61M | $74.58M | $50.67M | $45.17M | $59.94M | $49.76M | $27.3M | $24.2M | $27.09M | $28.82M | $29.73M | $44.29M |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $70M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.36M | $8.01B | $0 | $0 |
| Long-Term Unearned Revenue | $55.5M | $55.5M | $59.24M | $59.48M | $0 | $0 | $0 | $19M | $20.84M | $10.04M | $12.63M | $16.47M | $7.14M | $19.96M | $23.24M |
| Long-Term Deferred Tax Liabilities | $0 | $8.9M | $0 | $9.04M | $0 | $0 | $0 | $0 | $0 | $0 | $4.63M | -$3.69M | -$8B | $0 | $0 |
| Other Long-Term Liabilities | $1.05M | $1.97M | $258K | $258K | $258K | $6.93M | $9.15M | $10.31M | $4.05M | $5.17M | $9.1M | $6.36M | $8.01M | $12.3M | $12.64M |
| Total Long-Term Liabilities | $158.14M | $98.97M | $89.7M | $98.89M | $21.05M | $32.19M | $36.71M | $29.31M | $24.89M | $15.21M | $21.73M | $25.51M | $18.05M | $32.26M | $35.88M |
| Other Liabilities | $0 | -$8.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $201.25M | $145.6M | $145.81M | $147.5M | $95.63M | $82.86M | $81.87M | $89.25M | $74.64M | $42.51M | $45.93M | $52.6M | $46.87M | $61.98M | $80.16M |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.95M | $0 |
| Common Stock | $633K | $628K | $621K | $617K | $613K | $562K | $490K | $424K | $369K | $349K | $343K | $280K | $252K | $206K | $230K |
| Retained Earnings | -$1.24B | -$1.17B | -$1.1B | -$1.09B | -$973.94M | -$771.82M | -$642.08M | -$490.27M | -$312.34M | -$292.71M | -$234.19M | -$214.05M | -$175.73M | -$175.47M | -$183.83M |
| Comprehensive Income & Other | $32K | $4K | -$6K | -$5K | -$61K | -$7K | $16K | -$3K | -$61K | -$82K | -$5K | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $1.3B | $1.29B | $1.25B | $1.24B | $1.21B | $1.07B | $872.22M | $732.72M | $611.21M | $561.12M | $547.18M | $335.05M | $254.4M | $167.03M | $166.32M |
| Total Equity | $55.59M | $116.06M | $152.61M | $142.01M | $239.62M | $295.88M | $230.63M | $242.88M | $299.24M | $268.75M | $313.34M | $121.29M | $78.91M | -$8.24M | -$17.28M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $256.85M | $261.65M | $298.42M | $289.51M | $335.25M | $378.74M | $312.5M | $332.13M | $373.88M | $311.26M | $359.27M | $173.89M | $125.78M | $53.75M | $62.88M |
| Supplementary Data | |||||||||||||||
| Total Debt | $106.76M | $37.46M | $33.97M | $34.83M | $25.47M | $29.25M | $30.57M | $0 | $298K | $1.89M | $4.71M | $8.01M | $9.45B | $0 | $0 |
| Net Debt | $49.55M | -$145.38M | -$66.98M | -$74.05M | -$98M | -$151.88M | -$95.9M | -$220.13M | -$211.43M | -$82.21M | -$191.46M | -$149.59M | $9.33B | -$47.74M | -$55.22M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | -$74.62M | -$66.97M | -$9.06M | -$119.76M | -$202.12M | -$129.74M | -$151.81M | -$171.45M | -$19.63M | -$58.53M | -$20.14M | -$38.31M | -$261K | $8.36M | $6.72M |
| Depreciation & Amortization | $7.17M | $7.54M | $9.64M | $11.87M | $11.26M | $11.96M | $12.31M | $9.16M | $7.23M | $7.61M | $2.86M | $1.82M | $1.19M | $960K | $1.15M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | -$25.09M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $14.29M | $29.44M | $18.37M | $20.44M | $23.13M | $20.68M | $19.57M | $16.52M | $14.74M | $12.16M | $7.85M | $3.24M | $862K | $838K | $2.35M |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | -$9.06M | $6.06M | $45.85M | -$45.84M | $12.7M | -$10.34M | $16.84M | -$15.94M | -$10.88M | -$1.54M | $1.71M | -$931K | $42K | $1.35M | $12.55M |
| Inventory | -$7.91M | -$2.19M | $230K | $55K | -$6.42M | $0 | -$9.63M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$280K | -$1.53M | $1.28M | -$10.86M | $7.13M | $3.72M | $787K | $1.55M | -$1.54M | $2.23M | -$163K | -$1.5M | -$570K | -$7.31M | -$10.27M |
| Other Working Capital | -$11.08M | -$948K | $5.95M | $50.51M | $4.17M | -$7.92M | -$20.87M | $7.81M | $24.48M | -$5.62M | -$5.78M | $2.81M | -$15.69M | -$10.63M | -$4.28M |
| Total Working Capital Change | -$28.33M | $1.39M | $53.32M | -$6.13M | $17.57M | -$14.53M | -$12.88M | -$6.58M | $12.06M | -$4.92M | -$4.23M | $383K | -$16.22M | -$16.59M | -$2M |
| Other Non-Cash Items | $453K | -$39.78M | -$150.48M | $6.63M | $6.33M | -$260K | $23.63M | -$881K | $0 | $0 | $0 | $105K | $251K | -$151K | -$1.46M |
| Net Cash from Operating | -$81.04M | -$68.37M | -$78.2M | -$86.96M | -$143.83M | -$111.9M | -$134.27M | -$153.23M | $14.4M | -$43.68M | -$13.66M | -$32.76M | -$14.17M | -$6.58M | $6.76M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$1.91M | -$3.71M | -$1.76M | -$3.62M | -$6.2M | -$5.91M | -$4.29M | -$24.95M | -$29.4M | -$11.38M | -$9.2M | -$3.57M | -$2.96M | -$940K | -$500K |
| Acquisitions | $11K | $0 | $64K | $0 | $0 | $0 | $75.07M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$208.34M | -$77.18M | -$239.68M | -$120.6M | -$231.21M | -$223.75M | -$264.4M | -$132.75M | -$135.12M | -$347.76M | -$142.91M | $0 | $0 | $0 | $0 |
| Sales of Investments | $96.14M | $190.03M | $161.3M | $194.94M | $200.8M | $221.87M | $189.33M | $214.35M | $242.4M | $288.89M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $40.16M | $0 | $0 | $0 | $0 | -$75.07M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$114.1M | $149.3M | -$80.08M | $70.72M | -$36.61M | -$7.79M | -$79.36M | $56.64M | $77.88M | -$70.25M | -$152.11M | -$3.57M | -$2.96M | -$940K | -$500K |
| Financing Activities | |||||||||||||||
| Debt Repaid | - | - | $157K | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $129K | $3.44M | $1.17M | $1.08M | $117.82M | $176.35M | $118.66M | $103.26M | $34.24M | $1.89M | $203.47M | $76.72M | $85.87M | $47K | $70K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$2.01M | $0 | -$260K | -$40K | -$39K | -$29K | -$19K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $69.39M | -$2.48M | $149.35M | $574K | $4.96M | $3.89M | $1.31M | $1.99M | $1.14M | $1.89M | $911K | $744K | $0 | $0 | $0 |
| Net Cash from Financing | $69.51M | $960K | $150.36M | $1.66M | $122.78M | $174.34M | $119.97M | $104.99M | $35.35M | $1.85M | $204.35M | $77.44M | $85.87M | $47K | $12.09M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$125.62M | $81.88M | -$7.93M | -$14.59M | -$57.66M | $54.66M | -$93.66M | $8.4M | $127.63M | -$112.07M | $38.58M | $41.11M | $68.74M | -$7.48M | $18.34M |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$81.04M | -$68.37M | -$78.2M | -$86.96M | -$143.83M | -$111.9M | -$134.27M | -$153.23M | $14.4M | -$43.68M | -$13.66M | -$32.76M | -$14.17M | -$6.58M | $6.76M |
| Capital Expenditure | -$1.91M | -$3.71M | -$1.76M | -$3.62M | -$6.2M | -$5.91M | -$4.29M | -$24.95M | -$29.4M | -$11.38M | -$9.2M | -$3.57M | -$2.96M | -$940K | -$500K |
| Free Cash Flow | -$82.95M | -$72.08M | -$79.97M | -$90.58M | -$150.03M | -$117.8M | -$138.56M | -$178.19M | -$15M | -$55.06M | -$22.86M | -$36.33M | -$17.13M | -$7.52M | $6.26M |
| Cash at Beginning | $182.84M | $100.96M | $108.88M | $123.47M | $181.13M | $126.47M | $220.13M | $211.73M | $84.1M | $196.17M | $157.59M | $116.48M | $47.74M | $55.22M | $36.88M |
| Cash at End | $57.22M | $182.84M | $100.96M | $108.88M | $123.47M | $181.13M | $126.47M | $220.13M | $211.73M | $84.1M | $196.17M | $157.59M | $116.48M | $47.74M | $55.22M |